IDDI in the Media.
Read the articles related to our know-how and expertise in clinical research and how we optimize the design and conduct of clinical trials.
They Are Talking About IDDI
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé de Diagenode, IDDI, l’Université de Bruxelles, l’Institut Jules Bordet et l’Université de Liège. Ces acteurs unissent leur savoir à la science « […]
IDDI Simplifies Collaboration with Veeva Systems’ Vault eTMF Solution
IDDI, an international functional Contract Research Organisation (CRO) headquartered in Belgium, replaced its mix of a paper-based trial master file (TMF) and e-rooms with Veeva Systems’ cloud-based Vault eTMF solution, part of Veeva’s Development Suite. As a CRO that collects, […]
CluePoints Launches Powerful & Pragmatic Solution to Risk-Based Monitoring
A new Software for Risk-based Monitoring As biopharmaceutical sponsors search for the optimal approach to targeted monitoring and reduced Source Data Verification (SDV), CluePoints introduces an Intelligent Statistical approach like no other! A new software and service provider of Intelligent […]
A Central Statistical Monitoring of Data Quality in Clinical Trials
Central Statistical Monitoring of Data Quality in Clinical Trials IDDI announces publication on Central Statistical Monitoring: ‘A statistical approach to central monitoring of data quality in clinical trials published in Clinical Trials’ on June 8th. Online version is available at: http://journals.sagepub.com/doi/abs/10.1177/1740774512447898 ABSTRACT […]
IDDI – XClinical: The best of Two Worlds
Integrated EDC IWRS system: The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system. About ID-netTM ID-netTM is an Interactive Web Response System (IWRS) for centralized randomization and treatment allocation developed by IDDI in […]
IDDI Announces Collaborative Agreement with I-Biostat
IDDI, announces that it has signed a collaborative agreement with I-BioStat, the Interuniversity Institute for Biostatistics and statistical Bioinformatics, which links research and consultancy groups at the Universities of Hasselt and Leuven in Belgium. The agreement will enable IDDI and […]
IDDI Reports Successful Partnership with Tigenix for Approval of Chondrocelect
Successful Partnership with Tigenix for Approval of Chondrocelect for Cartilage Repair IDDI’s contributed statistical methodology towards approval of ChondroCelect® TiGenix’s lead product for the treatment of cartilage repair in the knee. Louvain-la-Neuve, August 27, 2009 – IDDI (International Drug Development […]